For patients with candida species osteomyelitis who have undergone extensive surgical debridement, do you routinely still recommend 6-12 months of antifungal therapy or opt for a shorter duration?

Do you routinely recommend 6-12 months of antifungal therapy for patients with Candida species osteomyelitis who have undergone extensive surgical debridement, or do you consider a shorter duration based on clinical response and patient-specific factors?

• Yes, I routinely recommend 6-12 months of antifungal therapy after extensive surgical debridement
• No, I usually opt for a shorter duration of antifungal therapy if extensive surgical debridement has been performed and the patient shows a good clinical response
• I determine the duration of antifungal therapy based on the patient’s individual risk factors and comorbidities
• Other